ES8104405A1 - Procedimiento para preparar una vacuna de virus de gripe - Google Patents

Procedimiento para preparar una vacuna de virus de gripe

Info

Publication number
ES8104405A1
ES8104405A1 ES491517A ES491517A ES8104405A1 ES 8104405 A1 ES8104405 A1 ES 8104405A1 ES 491517 A ES491517 A ES 491517A ES 491517 A ES491517 A ES 491517A ES 8104405 A1 ES8104405 A1 ES 8104405A1
Authority
ES
Spain
Prior art keywords
influenza virus
preparing
cells
influenza
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES491517A
Other languages
English (en)
Spanish (es)
Other versions
ES491517A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Cutter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21904398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8104405(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Laboratories Inc filed Critical Cutter Laboratories Inc
Publication of ES491517A0 publication Critical patent/ES491517A0/es
Publication of ES8104405A1 publication Critical patent/ES8104405A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
ES491517A 1979-05-15 1980-05-14 Procedimiento para preparar una vacuna de virus de gripe Expired ES8104405A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3923679A 1979-05-15 1979-05-15

Publications (2)

Publication Number Publication Date
ES491517A0 ES491517A0 (es) 1981-04-01
ES8104405A1 true ES8104405A1 (es) 1981-04-01

Family

ID=21904398

Family Applications (1)

Application Number Title Priority Date Filing Date
ES491517A Expired ES8104405A1 (es) 1979-05-15 1980-05-14 Procedimiento para preparar una vacuna de virus de gripe

Country Status (13)

Country Link
EP (1) EP0019218B2 (https=)
JP (1) JPS55153723A (https=)
AR (1) AR220838A1 (https=)
AT (1) ATE16454T1 (https=)
AU (1) AU535804B2 (https=)
CA (1) CA1122527A (https=)
DE (1) DE3071225D1 (https=)
DK (1) DK154749C (https=)
ES (1) ES8104405A1 (https=)
IL (1) IL60063A0 (https=)
NO (1) NO801443L (https=)
RO (1) RO79525B (https=)
YU (1) YU41923B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
CA2205015C (en) * 1994-11-10 2003-04-08 Otfried Kistner Method for producing biologicals in protein-free culture
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
EP0808361A4 (en) * 1994-11-16 2001-07-18 St Jude Childrens Res Hospital Novel replication process
DE19612967A1 (de) * 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE10144906B4 (de) * 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
US6830917B2 (en) * 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
US20090004222A1 (en) 2004-11-03 2009-01-01 O'hagan Derek Influenza Vaccination
US7883844B2 (en) 2006-05-11 2011-02-08 Juridical Foundation The Chemosero-Therapeutic Research Institute Method for propagating influenza virus
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
TW201012930A (en) * 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
EP3173097A3 (en) 2009-02-10 2017-07-12 Seqirus UK Limited Influenza vaccines with reduced amounts of squalene

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262962B1 (https=) * 1974-03-05 1977-11-04 Science Union & Cie

Also Published As

Publication number Publication date
AR220838A1 (es) 1980-11-28
IL60063A0 (en) 1980-07-31
ATE16454T1 (de) 1985-11-15
EP0019218A2 (de) 1980-11-26
RO79525A (ro) 1984-07-17
DK212580A (da) 1980-11-16
YU41923B (en) 1988-02-29
EP0019218B1 (de) 1985-11-13
RO79525B (ro) 1984-09-30
EP0019218B2 (de) 1995-03-01
AU535804B2 (en) 1984-04-05
DK154749B (da) 1988-12-19
JPS55153723A (en) 1980-11-29
DK154749C (da) 1989-05-16
NO801443L (no) 1980-11-17
YU126580A (en) 1983-12-31
JPH0124769B2 (https=) 1989-05-15
CA1122527A (en) 1982-04-27
ES491517A0 (es) 1981-04-01
DE3071225D1 (en) 1985-12-19
EP0019218A3 (en) 1981-03-25
AU5824480A (en) 1980-11-20

Similar Documents

Publication Publication Date Title
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
EP1108787A3 (en) Production of vaccines
DE2964276D1 (en) Live attenuated human hepatitis-a-virus, method for growing it in cell culture in vitro and composition comprising it
NO912642D0 (no) Fremstilling av proteiner ved bruk av homolog rekombinasjon.
ATE482267T1 (de) Tierzellen und verfahren für die replikation von influenza viren
ES2067528T3 (es) Lineas celulares continuas en la produccion de vbi.
DK0414475T3 (da) Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
SE7712700L (sv) Mikroberare for cellkulturer samt sett att framstella dem
HRP921354A2 (en) Matrix with cells adherently bounded to it, and the process for the production of viruses/virus antigenes
IE781315L (en) Virus cultivation
ES432385A1 (es) Un metodo de obtener una cepa de virus de la gripe.
ES8200398A1 (es) Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.
JPS5254019A (en) Method of making biological preparations
GB846755A (en) Bovine rhinotracheitis vaccine and methods of production
GB1279859A (en) Process for the production of enhanced levels of viral yield
NL7709998A (en) Foetal canine lung diploid cell line - for virus cultures esp. for rabies vaccine prodn.
AR212170A1 (es) Medio de cultivo de celulas para la produccion de virus utilizables en la elaboracion de vacunas y un procedimiento para la preparacion de una vacuna mediante dicho medio de cultivo
Lakhonina et al. Simplified methods for the isolation and preservation of axenic Lamblia cultures
ES448573A1 (es) Procedimiento para la obtencion de vacunas de virus.
UA21969A1 (uk) Спосіб виготовлеhhя іhактивоваhої культуральhої вакциhи проти хвороби ауескі
RU93048664A (ru) Способ суспензионного культивирования филовирусов в клеточных культурах на микроносителях
KR830002512A (ko) 세포 배양액내에서 인플루엔자 왁진의 제조방법
CA2250714A1 (en) Animal cells and processes for the replication of influenza viruses
SU1109990A1 (ru) Способ выращивания вируса ящура
FR2244456A1 (en) Anti-rabies vaccine - by cultivating on bovine cells